2004
DOI: 10.1016/j.clpt.2003.11.317
|View full text |Cite
|
Sign up to set email alerts
|

Traditional aqueous kava extracts inhibit CYP4501A2 in humans

Abstract: Purpose Consumption of traditional aqueous kava (Piper methysticum Forst. f.) extracts is common in the Pacific region, whereas commercial products have been withdrawn in many countries due to rare but severe hepatotoxicity. Previous in‐vitro studies suggest that kavalactones are metabolized via CYP450 and that they have an inhibitory effect on these enzymes, which may be relevant for interactions as well as for the mechanism by which kava rarely causes hepatotoxicity. Methods: In a cross‐over study, 6 healthy… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2005
2005
2005
2005

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…118 However, according to traditional use in vivo, kava extracts do have the potential to inhibit CYP1A2 but not CYP2D6, CYP2C19, CYP2E1, or CYP3A4 activity. 160 Aside from its potential role in hepatotoxicity, kava can cause drowsiness, which can be additive with other CNS-depressant drugs, including the benzodiazepines. 161 Kava also has the potential to cause Parkinsonian symptoms, which would interfere with the efficacy of anti-Parkinson drug regimens used by a patient.…”
Section: Kavamentioning
confidence: 99%
“…118 However, according to traditional use in vivo, kava extracts do have the potential to inhibit CYP1A2 but not CYP2D6, CYP2C19, CYP2E1, or CYP3A4 activity. 160 Aside from its potential role in hepatotoxicity, kava can cause drowsiness, which can be additive with other CNS-depressant drugs, including the benzodiazepines. 161 Kava also has the potential to cause Parkinsonian symptoms, which would interfere with the efficacy of anti-Parkinson drug regimens used by a patient.…”
Section: Kavamentioning
confidence: 99%